they've developed a drug which reduces the risk of hospitalization or death by around 50% in Covid patients. If authorized by regulatory bodies, the drug could be the first oral antiviral medicine for Covid.
The companies plan to seek emergency authorization for the antiviral Covid treatment after the medicine showed "compelling results" in clinical trials.Currencies The U.S. dollar index, which tracks the greenback against a basket of its peers, was at 93.956 after a recent decline from above 94.4. The Japanese yen traded at 110.96 per dollar, stronger than levels around 112 seen against the greenback last week. The Australian dollar changed hands at $0.7279 following a bounce late last week from around $0.72.
Evegrande is just one card in a collapsing house of cards!
Michael Burry Warns Retail Traders About the 'Mother of All Crashes'